| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 445.09B | 441.88B | 407.01B | 359.68B | 331.48B |
| Gross Profit | 215.41B | 187.63B | 170.46B | 142.62B | 121.87B |
| EBITDA | 95.10B | 105.65B | 92.68B | 71.20B | 61.71B |
| Net Income | 28.28B | 41.42B | 29.91B | 14.24B | 4.32B |
Balance Sheet | |||||
| Total Assets | 1.14T | 1.16T | 1.11T | 1.12T | 1.19T |
| Cash, Cash Equivalents and Short-Term Investments | 36.10B | 54.98B | 71.34B | 39.87B | 93.28B |
| Total Debt | 336.68B | 363.58B | 364.40B | 413.95B | 502.11B |
| Total Liabilities | 713.54B | 740.91B | 720.49B | 749.54B | 830.78B |
| Stockholders Equity | 415.59B | 409.65B | 381.90B | 359.38B | 350.37B |
Cash Flow | |||||
| Free Cash Flow | 52.84B | 71.40B | 83.66B | 56.84B | 44.05B |
| Operating Cash Flow | 66.99B | 85.81B | 90.69B | 65.48B | 49.87B |
| Investing Cash Flow | -15.15B | -28.31B | 13.43B | -13.37B | -5.29B |
| Financing Cash Flow | -70.78B | -74.00B | -72.75B | -105.69B | -80.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥1.45T | 19.13 | 9.37% | 2.59% | -1.78% | 51.07% | |
70 Outperform | ¥797.90B | 28.58 | 7.58% | 2.58% | 0.73% | -29.62% | |
68 Neutral | ¥349.97B | 11.16 | 4.97% | 2.01% | -0.23% | -17.40% | |
64 Neutral | ¥1.92T | 31.25 | 17.34% | 0.72% | 16.20% | 16.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥993.38B | 10.86 | 9.25% | 1.48% | 2.96% | 13.23% | |
58 Neutral | ¥765.46B | -94.70 | 9.06% | 1.84% | -1.23% | -124.02% |